Monday, September 16, 2019 1:49:39 PM
They've been working with the FDA for at least a couple years now so both sides understand the expectations. It is not inconceivable that the IDE comes back approved very quickly instead of the max allowable 30 days, given the history of interaction between the two organizations (Titan and FDA).
IDE approval should mean the FDA is at least convinced of some substantial level of safety and presumably also efficacy before granting the IDE.
Also, coincidentally (or not!), Columbia University is a viable IRB organization for single site or multi site studies (we have up to four sites to utilize) and Dr. Advincula hangs out at Colombia and hopefully will be involved in our IRB process.
We are so freakin' close...
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM